Investors Yank $255 Million From Biotech ETFBy
SPDR S&P Biotech ETF saw $255 million outflow on Friday
Index of drugmakers has surged 19 percent over past 5 weeks
Once again, biotech is too hot to handle.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.